SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Heliums rally is being tied primarily to reported adoption by Celina, Texas, where the city is using the Helium networksupporting the broader DePIN and real-world wireless utility narrative. Bullish traders view the development as fuel for continued momentum and a possible short squeeze, while skeptics point to weak hotspot economics, dilution, and management concerns.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A BMF short report questioning the statistical power, control arm, and valuation of SELLASs REGAL Phase 3 AML trial drove attention and selling pressure. Traders remain divided: bears see meaningful downside risk if the trial fails, while bulls dismiss the report and focus on the pending 80th-event announcement and topline readout as potential catalysts.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

A stronger-than-expected quarterly update and higher full-year outlook, combined with broad rotation into healthcare defensives, are driving attention toward Johnson & Johnson. Traders are balancing growth in Innovative Medicine and new products against MedTech softness, patent erosion and lingering talc-related liabilities.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

U.S. tariffs on foreign-made drones and components, alongside anticipated Pentagon spending on domestic drone production, are driving attention to Red Cat as a potential beneficiary. Traders remain divided, with bulls expecting contract awards and Gauntlet II-related momentum, while skeptics point to the lack of confirmed major orders, ongoing losses, dilution, and managements promotional commentary.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas personalized mRNA cancer vaccine, used with Keytruda, met key Phase 3 recurrence and metastasis endpoints in resected melanoma, renewing enthusiasm for Mercks oncology pipeline and helping drive the shares to new highs. Traders remain divided over how much of the opportunity is already priced in, with pending full data, regulatory review, manufacturing complexity and Keytrudas eventual patent expiry cited as risks.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

Broad-market diversification and buy-and-hold investing are driving attention, with traders describing VTI as a core portfolio anchor and defensive option amid volatility. Others debate its heavy exposure to mega-cap technology and warn that an AI correction, rising rates, debt concerns, and geopolitical risk could pressure the broader index.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels completed acquisition of Australian Strategic Materials, including the Korean Metals Plant, is fueling discussion about its strategy to build a Western mine-to-magnet rare-earth supply chain alongside its uranium business. Traders are divided between those focused on the strategic minerals, defense and nuclear upside and those frustrated by weak price action, execution risks and profitability concerns.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Treasury Secretary Scott Bessents expanded long-duration Treasury buyback plan is driving attention, with traders speculating it could suppress yields and trigger a short squeeze in TLT. Skeptics argue the intervention is too small to overcome persistent inflation, heavy borrowing and hawkish Fed signals, leaving long-term yieldsand TLTvolatile.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Visas monitoring of Hims & Hers over elevated credit-card disputes tied to its weight-loss subscriptions, alongside ongoing FTC scrutiny, is driving attention and the sharp selloff. Traders disagree on whether the issues are an overblown near-term shock or could force costly changes to the business and weigh on customer confidence, while long-term bulls remain focused on GLP-1, peptide, and telehealth growth.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech rotation and renewed interest in the sectorhighlighted by Moderna and Mercks positive personalized cancer-vaccine datahas driven much of the attention around XBI. Traders remain divided over whether the rally can continue, with higher Treasury yields and rate-hike concerns blamed for sharp pullbacks in the rate-sensitive ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SS Innovations International (NASDAQ: SSII) Indian Surgical Robotics Growth Points to Broader Market Opportunity

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is gaining another indication of the scale that its SSi Mantra surgical robotic system can support in India, where more than 50 robotic procedures were performed in a single day at Mohak Bariatrics and Robotics in Indore. The milestone, announced by SS Innovations […]

India’s Medical-Device Market Surge Seen as Major Growth Opportunity for SS Innovations International (NASDAQ: SSII)

India’s next major manufacturing opportunity may emerge not from information technology or semiconductors, but from medical devices. An observation from business developer Shaad Merchant, quoting a recent report from Rubix Industry Insights, shows India’s medical-device market projected to increase from $15.2 billion in 2025 to $50.1 billion by 2030, representing a compound annual growth rate […]

SS Innovations International (NASDAQ: SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, delivered another quarter of rapid top-line growth as demand for its SSi Mantra surgical robotic system continued to expand. The company reported second-quarter 2026 revenue of $13.9 million, an increase of 39.4% from $10.0 million a year earlier. Gross profit increased 20.0% to […]

SS Innovations International (NASDAQ: SSII) Reports Record Q2 Revenue of $13.9M, Up 39.4%

SS Innovations International (NASDAQ: SSII) reported record second-quarter 2026 revenue of $13.9 million, up 39.4% from $10 million a year earlier, as installations of its SSi Mantra surgical robotic system increased 30.4% to 30. Gross profit rose 20% to $7.1 million, with gross margin of 50.9%, while net loss was $2.7 million, or $0.01 per [&#8230;]

SS Innovations International (NASDAQ: SSII) Expands Global Footprint on Fast-Growing Robotic Surgery Market

The market for robotic-assisted surgery continues to evolve as healthcare systems seek technologies that can improve surgical precision while expanding patient access. Within that landscape, SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has positioned itself around a strategy centered on unmatched technology, physician training, international expansion, and affordability. Serving as [&#8230;]

SS Innovations International (NASDAQ: SSII) to Showcase SSi Mantra Surgical Robotic System at SRS 2026

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, will bring its SSi Mantra surgical robotic system to one of the largest annual gatherings of robotic surgery specialists, highlighting the company’s expanding clinical experience and growing focus on remote surgical capabilities. The company announced that the SSi Mantra will be showcased during [&#8230;]

SS Innovations International (NASDAQ: SSII) Strengthens Leadership as Global Robotic Surgery Expansion Gains Pace

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, adding public-company financial and capital markets experience as the surgical robotics developer continues its global expansion and advances regulatory initiatives. The appointment, effective August 3, comes at a time […]

SS Innovations International (NASDAQ: SSII) to Showcase SSi Mantra at Society of Robotic Surgery Annual Meeting

SS Innovations International (NASDAQ: SSII) announced its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from […]

SS Innovations International (NASDAQ: SSII) Appoints Sarah Romano as Chief Financial Officer

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors and will help lead the company’s financial operations as it […]

SS Innovations International (NASDAQ: SSII) CEO Outlines Strategy to Expand Affordable Robotic Surgery

For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. That was the focus of a recent Medsider interview with Dr. Sudhir Srivastava, founder, chairman and CEO of SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, who discussed the company&#8217;s strategy [&#8230;]

SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. Its proprietary software integrates Artificial Intelligence (AI) and Deep Learning, or machine learning (DL). It focuses on research and development to an AI-enhanced robotics platform system that can be combined with proven medical devices, end-effectors, and surgical instruments. The company was founded by Barry F. Cohen on February 4, 2015 and is headquartered in Fort Lauderdale, FL.

SS Innovations International Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

SSII SS Innovations International Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SSII News